Novo Nordisk Beating Lilly in Obesity Pill Market: What It Means for Investors
Novo Nordisk is gaining ground on Lilly in the obesity pill market. This article breaks down the drivers, the competi...
Retirees benefit from selecting tax-efficient asset classes and optimized withdrawal sequencing. Learn which classes to favor and why.
23,930 articlesNovo Nordisk is gaining ground on Lilly in the obesity pill market. This article breaks down the drivers, the competi...
Dell Technologies beats expectations, validating its AI-focused partnership with Palantir and sending Palantir shares...
A single indicator could steer the next 12 months for the iShares 20+ Year Treasury Bond ETF (TLT). If the 30-year yi...
A sharp intraday move in uranium miners has investors asking what really sparked the rally. This article dives into t...
A growing share of twenty-somethings hold two or more jobs and side hustles, raising questions about retirement readi...
Investors rotated into defensive names, helping Molina Healthcare stock cruised to near-a-10% weekly gain. Learn what...
At Fortune Brainstorm Tech in Aspen, Twitch CEO Dan Clancy argued that live streaming builds real human connection th...
iQIYI is betting on AI to revive growth as its core subscription business falters. With Nadou Pro signing thousands o...
As fintech payments consolidates, private equity eyes these three beaten-down names, weighing growth, cash flow, and ...
A historic IPO sparked a wave of leveraged ETFs designed to amplify daily moves. This report breaks down how they wor...
A broad sell-off hit four key quantum names after a sharp Monday rally, with profit-taking and sentiment shifts weigh...
A daring forecast from Goldman Sachs imagines SpaceX turning into a multi-hundred-billion-dollar revenue machine by 2...